These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 80633)

  • 21. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
    Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
    Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure?
    Christiansen C; Rødbro P; Christensen MS; Hartnack B
    Clin Endocrinol (Oxf); 1981 Sep; 15(3):229-36. PubMed ID: 6273027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A
    Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in vitamin D metabolism as they pertain to chronic renal disease.
    Coburn JW; Hartenbower DL; Brickman AS
    Am J Clin Nutr; 1976 Nov; 29(11):1283-99. PubMed ID: 187055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of vitamin D: current status.
    DeLuca HF
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA; Woodhead JS; Brown RC
    Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic renal failure and vitamin D metabolites: a status report.
    Christiansen C
    J Steroid Biochem; 1983 Jul; 19(1B):517-23. PubMed ID: 6310241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolism of a physiological dose of radioactive cholecalciferol (vitamin D3) to its hydroxylated metabolites in man.
    Stanbury SW; Mawer EB
    Clin Sci (Lond); 1980 Jun; 58(6):523-35. PubMed ID: 6253118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D metabolism and parathyroid function in man.
    Mawer EB; Backhouse J; Hill LF; Lumb GA; De Silva P; Taylor CM; Stanbury SW
    Clin Sci Mol Med; 1975 May; 48(5):349-65. PubMed ID: 165031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
    Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
    Kanis JA; Russell RG
    Br Med J; 1977 Jan; 1(6053):78-81. PubMed ID: 832019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitriol in dialysis patients.
    Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC
    Clin Pharmacol Ther; 1978 May; 23(5):515-9. PubMed ID: 205382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure.
    Gal-Moscovici A; Rubinger D; Popovtzer MM
    Clin Nephrol; 2000 May; 53(5):362-71. PubMed ID: 11305809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
    Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC; Kleit SA
    Proc Clin Dial Transplant Forum; 1977; 7():166-9. PubMed ID: 210446
    [No Abstract]   [Full Text] [Related]  

  • 40. Biologic effect of 1,24(R)(OH)2D3 versus 1,25(OH)2D3 administration in chronic renal failure.
    Coen G; Bondatti F; Donato G; Mazzaferro S; Pasquali M; Rosini S; Sardella D; Taggi F
    J Steroid Biochem Mol Biol; 1992 Sep; 42(8):823-9. PubMed ID: 1525043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.